Our Multiple Sclerosis Research

Patients have the opportunity to participate in clinical trials at NewYork-Presbyterian Hospital assessing new therapies for MS to limit disease progression and restore function. Clinical researchers also collaborate with molecular biologists, immunologists, and neuroscientists to:

  • Examine the molecular basis of the myelin degeneration that occurs in people with MS
  • Identify molecular targets for new therapies
  • Develop new imaging methods to visualize and quantify nerve cells, myelin, and inflammation in MS
  • Develop potential therapies to promote the regeneration of myelin
  • Define the environmental causes of MS